BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 659663)

  • 1. In situ injection of kainic acid: a new method for selectively lesioning neural cell bodies while sparing axons of passage.
    Coyle JT; Molliver ME; Kuhar MJ
    J Comp Neurol; 1978 Jul; 180(2):301-23. PubMed ID: 659663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kainic acid: insights from a neurotoxin into the pathophysiology of Huntington's disease.
    Coyle JT; Ferkany JW; Zaczek R
    Neurobehav Toxicol Teratol; 1983; 5(6):617-24. PubMed ID: 6142425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural evaluation of the damage of postsynaptic elements after kainic acid injection into the rat neostriatum.
    Matyja E
    J Neurosci Res; 1986; 15(3):405-13. PubMed ID: 3701889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fate of the hippocampal mossy fiber projection after destruction of its postsynaptic targets with intraventricular kainic acid.
    Nadler JV; Perry BW; Gentry C; Cotman CW
    J Comp Neurol; 1981 Mar; 196(4):549-69. PubMed ID: 7204671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ibotenic acid-induced lesions of striatal target and projection neurons: ultrastructural manifestations in dopaminergic and non-dopaminergic neurons and in glia.
    Smith DE; Saji M; Joh TH; Reis DJ; Pickel VM
    Histol Histopathol; 1987 Jul; 2(3):251-63. PubMed ID: 2908792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of effects of kainic acid lesions in the dorsal lateral geniculate nucleus of rat.
    Woodward WR; Coull BM
    J Comp Neurol; 1982 Oct; 211(1):93-103. PubMed ID: 6184387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An animal model for Huntington's disease.
    Coyle JT
    Biol Psychiatry; 1979 Apr; 14(2):251-76. PubMed ID: 38864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local and distant neuronal degeneration following intrastriatal injection of kainic acid.
    Zaczek R; Simonton S; Coyle JT
    J Neuropathol Exp Neurol; 1980 May; 39(3):245-64. PubMed ID: 6154134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of intracaudate administration of kainic acid on the activity of the dopaminergic system].
    Zharkovskiĭ AM; Nurk AM
    Fiziol Zh SSSR Im I M Sechenova; 1981 Nov; 67(11):1606-10. PubMed ID: 6799331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of target tissue in regulating the development of retinal ganglion cells in the albino rat: effects of kainate lesions in the superior colliculus.
    Carpenter P; Sefton AJ; Dreher B; Lim WL
    J Comp Neurol; 1986 Sep; 251(2):240-59. PubMed ID: 3782500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal lesions with kainic acid: neurochemical characteristics.
    Schwarcz R; Coyle JT
    Brain Res; 1977 May; 127(2):235-49. PubMed ID: 16686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABA receptor binding in rat striatum: localization and effects of denervation.
    Campochiaro P; Schwarcz R; Coyle JT
    Brain Res; 1977 Nov; 136(3):501-11. PubMed ID: 922498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroexcitatory properties of kainic acid. II) Neuronal damages following intracerebreal microinjections in behavioural rats.
    Ricciardi G; Forchetti C; Gasbarri A; Scarnati E; Pacitti C
    Boll Soc Ital Biol Sper; 1981 Apr; 57(8):919-25. PubMed ID: 7272068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of intracerebroventricularly applied kainic acid on acetylcholine content and release in rat brain cortex and striatum.
    Kleinrok A; Tomaszewski A; Billewicz-Stankiewicz J
    Pol J Pharmacol Pharm; 1981 Nov; 33(4):453-8. PubMed ID: 7329869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degeneration of hippocampal CA3 pyramidal cells induced by intraventricular kainic acid.
    Nadler JV; Perry BW; Gentry C; Cotman CW
    J Comp Neurol; 1980 Jul; 192(2):333-59. PubMed ID: 7400401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine structural analysis of the cortico-striatal pathway.
    Hattori T; McGeer EG; McGeer PL
    J Comp Neurol; 1979 May; 185(2):347-53. PubMed ID: 34635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological changes of striatal dopaminergic presynaptic boutons following intrastriatal kainate injection.
    Moriizumi T; Takada M; Hattori T
    Neuropharmacology; 1991 Jul; 30(7):813-7. PubMed ID: 1922691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontogenetic development of kainate neurotoxicity: correlates with glutamatergic innervation.
    Campochiaro P; Coyle JT
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):2025-9. PubMed ID: 25442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of neurotensinlike immunoreactivity in the striatum of the cat after intrastriatal injection of kainic acid.
    Sugimoto T; Itoh K; Yasui Y; Kamiya H; Uemura Y; Mizuno N
    J Comp Neurol; 1987 Sep; 263(4):607-12. PubMed ID: 3667991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrastriatal kainic acid: acute effects on electrophysiological and biochemical measures of nigrostriatal dopaminergic activity.
    Braszko JJ; Bannon MJ; Bunney BS; Roth RH
    J Pharmacol Exp Ther; 1981 Feb; 216(2):289-93. PubMed ID: 6257886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.